You searched for "Refraction"
Long-term meibomian gland function following a single thermal pulsation treatment
1 December 2013
| Kwesi Amissah-Arthur
|
EYE - Cornea, EYE - General
|
LipiFlow thermal pulsation system, dry eye, meibomian gland dysfunction
Dry eyes secondary to blepharitis and or meibomian gland dysfunction, though extremely common, is an annoyingly difficult condition to treat for several patients. Part of this difficulty lies in the inability of most patients to follow intensive and often times...
Surgical treatment for monocular elevation deficit
Type 1 monocular elevation deficiency is a restrictive form identified by positive results on forced duction testing in elevation, normal elevation forced generation test, elevation of saccadic velocity and absence of poor Bell’s phenomenon. The authors aimed to evaluate the...
A phase 3 randomised trial of nicotinamide for skin cancer chemoprevention
To B3, or not to B3? That was the question asked in this controlled trial in which the authors were able to show that oral nicotinamide (vitamin B3) is able to reduce further skin cancer development in high risk patients....
Minimally Invasive Glaucoma Surgery – A Practical Guide
1 October 2017
| Indira Madgula
|
EYE - Glaucoma
The treatment of patients with mild to moderate glaucoma has evolved rapidly in the last decade. Traditionally, medical and laser treatments were the mainstay of therapy for this group of patients. Trabeculectomy, non-penetrating surgery and glaucoma drainage implants were reserved...
Spontaneous resolution of inferior oblique over action
The purpose of this study was to evaluate the course of over-elevation in adduction in patients who had surgery for esotropia. Following a chart review, 28 patients met the inclusion criteria with a mean age of 53.5±53.7 months (12-252 months)....
Treatment of Type 1 ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone
This is a retrospective review of charts of 54 consecutive very low birth weight (VLBW) infants between June 2011 and January 2015 from Berlin, Germany. Type 1 ROP (posterior ROP, n=33; peripheral zone 2, n= 21) were treated with either...
Efficacy of IVC injection in the treatment of ROP
2 December 2019
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a retrospective consecutive case series of patients who received intravitreal conbercept (IVC) as a primary treatment from June 2015 to July 2016 for treatment of retinopathy of prematurity (ROP). Forty-eight eyes of 24 patients were included in the...
Infection prevention and control through a VISION 2020 LINK between Mombasa and Southampton
1 April 2017
| Ross Cahill, Lizzi Lewis, Majula Rajamani, Truphosa Imali, Phenny Khandoro, George Binns, George Munywoki, Colin Elkin, Samantha Palmer, Dario Inzerillo, Aby Jacob, Marcia Zondervan
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
The authors share how a partnership between Mombasa and Southampton has enabled Kenyan healthcare professionals from four institutions to innovate and work as a group to improve infection prevention and control. Infection prevention and control (IPC) is a cornerstone of...
Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease
In recent years artificial tear drops addressing tear film osmolarity have come onto the market. Increased tear evaporation and reduced tear volume results in tear hyperosmolarity. This triggers an inflammatory process leading to apoptosis of goblet and epithelial cells. Trehalose,...The University of Edinburgh - Supporting Future Leaders in Ophthalmology
8 June 2022
The University of Edinburgh announce plan to award twelve scholarships this summer for successful international applicants to their Master of Surgery (ChM) in Clinical Ophthalmology programme. Deadline for application closes 15th June.
Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up
29 March 2023
|
glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.
Making the most of your foundation year rotation in ophthalmology
18 June 2025
| Rohan Aziz
|
EYE - General
Ophthalmology continues to be a highly desirable speciality in the UK; however, medical students usually encounter only minimal exposure, generally ranging from one to two weeks, during their studies [1]. Nevertheless, eye-related conditions represent a considerable share of presentations in...
